RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Kelly McKee, M.D., as Executive Director of Operations for the company's Public Health and Government Services unit. McKee brings tremendous experience and expertise in infectious diseases and vaccine product development. He will report to Oren Cohen, M.D., Quintiles' Chief Medical and Scientific Officer, and Head of the Public Health and Government Services unit.
"Kelly will play an important alliance management role with government and commercial sponsors as well as Quintiles internal resources," Cohen said. "Our team is resourced and committed to assisting pharmaceutical and biotech companies win government contracts to advance public health."
Prior to his appointment as Executive Director of Operations, McKee served as Senior Director, Medical and Scientific Services (Infectious Diseases) for Quintiles where he was responsible for providing medical support to investigative sites. Previously, he served as Senior Director for Clinical Research for DynPort Vaccine Company where he directed clinical trials.
McKee earned his medical degree from the University of Virginia School of Medicine and completed his internship, residency and fellowship training in pediatrics and pediatric infectious diseases at Vanderbilt University Hospital. He completed a 20-year career in the U.S. Army Medical Department, during which he completed residency training in Preventive Medicine at the Walter Reed Army Institute of Research. McKee also earned a Master's degree in Public Health from Johns Hopkins University School of Hygiene and Public Health.
About Quintiles Public Health and Government Services
Quintiles Public Health and Government Services has the expertise and experience to develop products that improve global public health and enhance readiness to respond to bioterrorism threats, through its partnerships with governments, non-governmental organizations (NGOs) and the biopharmaceutical industry.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With about 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at www.quintiles.com.
SOURCE Quintiles Transnational Corp.